Creating a positive impact on the Pharma Industry and Patients
OUR CAPABILITIES
DATA
World’s Largest Data Ocean
of Public and Proprietary Data
326M+
Web
Domains
50k+
Sources
Updated Daily
1M+
Clinical Trials &
Preclinical Studies
40M+
Biomedical
Terms & Concepts
1.5M+
Patients
Records
Real World Data Exchange
Transforming the Healthcare Industry through data licensing and incentivizing patients
2.5M+
App Downloads
Decision Making
Answering the most important questions in developing treatment for incurable diseases
Artificial Intelligence 
AI-Enabled Novel
Hypotheses Across LS
Value Chain
Hypotheses Across LS
Value Chain
Successfully
Used by 50+
Organisations
Used by 50+
Organisations
Up to 50%
Time-Saving in
Drug Discovery
Time-Saving in
Drug Discovery
65+ Patents,
125+ Patents
Filed
125+ Patents
Filed
In-Vitro Validation 
High Throughput
Screening Capabilities
Screening Capabilities
Biophysical
Characterization
Characterization
Medicinal Chemistry and
de-novo Molecule Manufacturing
de-novo Molecule Manufacturing
DRUG ASSETS
A Portfolio of Partnered &
In-House Assets
Proprietary
Asset Pipeline
Asset Pipeline
30 Drug Discovery
Partnerships
Partnerships
What We Have
Achieved until today
50+
Global Pharma/Biotech Customers
1
Drug Assets inDevelopment Pipeline
30
Established DrugDiscovery Partnerships
2.5M+
EcosystemDownloads
1.5M+
Patients’ RecordsPatents
65+
Granted125+
Filed500+
Employees2 PFLOPS
ComputingPower
OUR LOCATIONS
Our latest News
“Leading Somebody Is Like Serving Somebody” Chairman, Co-Founder Partex NV
Leaders of Tomorrow | Season 10 Partex NV | ET NOW | Business News
Partex NV’s Amrit AG & YouWeCan Cancer Foundation partner to celebrate new milestone
Francisco Fernandez brings two billion dollar companies to Zug
Swiss artificial intelligence firm gains rights to first candidate
Partex welcomes ASSAY.WORKS to its digital pharma platform
Yuvraj Singh as ambassador for Curia, an app that provides information on cancer treatment
Artificial intelligence should support the treatment of urological tumors